RNS & Investor News

Rule 2.9 Announcement

17 August 2020

In accordance with Rule 2.9 of the City Code on Takeovers and Mergers, Collagen Solutions plc confirms that it has 446,878,910 ordinary share in issue ("Ordinary Shares") following the "Allotment of shares to employee benefit trust and Total Voting Rights" announcement on 12 August 2020. The International Securities Identification Number (ISIN) reference for these securities is GB00B94T6Y14. The Company does not hold any shares in treasury.

 

For further information please contact:

 

Collagen Solutions Plc
Jamal Rushdy, Chief Executive Officer
Hilary Spence, Chief Financial Officer
Contact via Walbrook

Cenkos Securities Plc (Nominated Adviser and Broker)
Giles Balleny
Stephen Keys

Tel: 0207 397 8900


Walbrook PR Tel: 020 7933 8780 or [email protected]
Mob: 07876 741 001

Global Delivery

Qualified shippers ensure the product reaches its destination safely within client time and temperature protocols around the globe.

Quality Certifications

logo_gmp edqm logo_bsi logo_bsi_2

Need a Custom Formulation?

We will formulate a product specifically for your application.
Please contact us to discuss your requirements for collagen biomaterials.

Contact Us